Author
Listed:
- Elsa du Bruyn
(University of Cape Town
University of Cape Town)
- Cari Stek
(University of Cape Town
University of Cape Town
Imperial College London)
- Remi Daroowala
(University of Cape Town
University of Cape Town
Imperial College London)
- Qonita Said-Hartley
(University of Cape Town)
- Marvin Hsiao
(University of Cape Town
National Health Laboratory Service, Groote Schuur Complex, Department of Clinical Virology)
- Georgia Schafer
(University of Cape Town
University of Cape Town
International Centre for Genetic Engineering and Biotechnology (ICGEB))
- Rene T. Goliath
(University of Cape Town)
- Fatima Abrahams
(University of Cape Town)
- Amanda Jackson
(University of Cape Town)
- Sean Wasserman
(University of Cape Town
University of Cape Town)
- Brian W. Allwood
(Stellenbosch University and Tygerberg Hospital)
- Angharad G. Davis
(University of Cape Town
The Francis Crick Institute
University College London)
- Rachel P.-J. Lai
(University of Cape Town
Imperial College London
The Francis Crick Institute)
- Anna K. Coussens
(University of Cape Town
University of Cape Town
The Walter and Eliza Hall Institute of Medical Research)
- Katalin A. Wilkinson
(University of Cape Town
University of Cape Town
The Francis Crick Institute
University College London)
- Jantina de Vries
(University of Cape Town)
- Nicki Tiffin
(University of Cape Town
Western Cape Department of Health
University of Cape Town
University of Cape Town)
- Maddalena Cerrone
(University of Cape Town
Imperial College London
The Francis Crick Institute)
- Ntobeko A. B. Ntusi
(University of Cape Town
University of Cape Town)
- Catherine Riou
(University of Cape Town
University of Cape Town)
- Robert J. Wilkinson
(University of Cape Town
University of Cape Town
Imperial College London
The Francis Crick Institute)
Abstract
Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2 infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an African setting of high HIV-1 and tuberculosis prevalence by an observational case cohort of SARS-CoV-2 patients. A comparator group of non SARS-CoV-2 participants is included. The study includes 104 adults with SARS-CoV-2 infection of whom 29.8% are HIV-1 co-infected. Two or more co-morbidities are present in 57.7% of participants, including HIV-1 (30%) and active tuberculosis (14%). Amongst patients dually infected by tuberculosis and SARS-CoV-2, clinical features can be typical of either SARS-CoV-2 or tuberculosis: lymphopenia is exacerbated, and some markers of inflammation (D-dimer and ferritin) are further elevated (p
Suggested Citation
Elsa du Bruyn & Cari Stek & Remi Daroowala & Qonita Said-Hartley & Marvin Hsiao & Georgia Schafer & Rene T. Goliath & Fatima Abrahams & Amanda Jackson & Sean Wasserman & Brian W. Allwood & Angharad G., 2023.
"Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-022-35689-1
DOI: 10.1038/s41467-022-35689-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-022-35689-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.